153 related articles for article (PubMed ID: 26879691)
21. Chronic Myelomonocytic Leukemia Presenting With Polyserositis and Seropositivity for Rheumatoid Arthritis.
Kunnumpurath A; Desikan SP; McClain C; Desikan R
J Investig Med High Impact Case Rep; 2020; 8():2324709620966863. PubMed ID: 33084368
[TBL] [Abstract][Full Text] [Related]
22. RAS mutations contribute to evolution of chronic myelomonocytic leukemia to the proliferative variant.
Ricci C; Fermo E; Corti S; Molteni M; Faricciotti A; Cortelezzi A; Lambertenghi Deliliers G; Beran M; Onida F
Clin Cancer Res; 2010 Apr; 16(8):2246-56. PubMed ID: 20371679
[TBL] [Abstract][Full Text] [Related]
23. Antecedent cardiovascular disease and autoimmunity in Philadelphia-negative chronic myeloproliferative neoplasms.
Sørensen AL; Hasselbalch HC
Leuk Res; 2016 Feb; 41():27-35. PubMed ID: 26718091
[TBL] [Abstract][Full Text] [Related]
24. [Rheumatologic manifestations of chronic myelomonocytic leukemia. Presentation of 2 cases].
Martino R; Nomdedéu JF; Brunet S; Sureda A; Montagut M; Domingo-Albós A
Sangre (Barc); 1993 Dec; 38(6):493-6. PubMed ID: 8171386
[TBL] [Abstract][Full Text] [Related]
25. Relationship between autoimmune phenomena and disease stage and therapy in B-cell chronic lymphocytic leukemia.
Barcellini W; Capalbo S; Agostinelli RM; Mauro FR; Ambrosetti A; Calori R; Cortelezzi A; Laurenti L; Pogliani EM; Pedotti P; Liso V; Girelli G; Mandelli F; Zanella A;
Haematologica; 2006 Dec; 91(12):1689-92. PubMed ID: 17145607
[TBL] [Abstract][Full Text] [Related]
26. Risks and outcomes of hospitalizations in patients with chronic lymphocytic leukemia admitted with immune thrombocytopenia: an analysis of the National Inpatient Sample Database.
Ammad Ud Din M; Mahmud A; Mostafa M; Shahzad M; Liaqat H; Pinilla-Ibarz J; Jaglal M
Ann Hematol; 2023 Apr; 102(4):889-895. PubMed ID: 36781419
[TBL] [Abstract][Full Text] [Related]
27. A case of chronic myelomonocytic leukemia complicated with spondyloarthritis.
Matsumoto T; Saito T; Kohsaka H
Mod Rheumatol; 2018 Mar; 28(2):373-375. PubMed ID: 26392142
[TBL] [Abstract][Full Text] [Related]
28. Secondary autoimmune cytopenias in chronic lymphocytic leukemia.
Rogers KA; Woyach JA
Semin Oncol; 2016 Apr; 43(2):300-10. PubMed ID: 27040709
[TBL] [Abstract][Full Text] [Related]
29. Survivin expression, apoptosis and proliferation in chronic myelomonocytic leukemia.
Invernizzi R; Travaglino E; Benatti C; Malcovati L; Della Porta M; Cazzola M; Ascari E
Eur J Haematol; 2006 Jun; 76(6):494-501. PubMed ID: 16529600
[TBL] [Abstract][Full Text] [Related]
30. Chronic inflammatory demyelinating polyneuropathy accompanied by chronic myelomonocytic leukemia: possible pathogenesis of autoimmunity in myelodysplastic syndrome.
Isoda A; Sakurai A; Ogawa Y; Miyazawa Y; Saito A; Matsumoto M; Sawamura M
Int J Hematol; 2009 Sep; 90(2):239-242. PubMed ID: 19588217
[TBL] [Abstract][Full Text] [Related]
31. Autoimmune disease in CMML-the chicken or the egg?
Ambinder AJ; Miller J; DeZern AE
Best Pract Res Clin Haematol; 2020 Jun; 33(2):101136. PubMed ID: 32460986
[TBL] [Abstract][Full Text] [Related]
32. Targeted ex vivo reduction of CD64-positive monocytes in chronic myelomonocytic leukemia and acute myelomonocytic leukemia using human granzyme B-based cytolytic fusion proteins.
Schiffer S; Rosinke R; Jost E; Hehmann-Titt G; Huhn M; Melmer G; Barth S; Thepen T
Int J Cancer; 2014 Sep; 135(6):1497-508. PubMed ID: 24523193
[TBL] [Abstract][Full Text] [Related]
33. Chronic myelomonocytic leukemia presenting as relapsing thrombotic thrombocytopenic purpura.
Cai Y; Teng R; Lin Z; Zhang Y; Liu H
Aging Clin Exp Res; 2013 Jun; 25(3):349-50. PubMed ID: 23740594
[TBL] [Abstract][Full Text] [Related]
34. Chronic myelomonocytic leukemia mimicking hematologic systemic lupus erythematosus.
Moura CA; Santiago M; Neto J; Gomes de Souza VH; Moura CG
Lupus; 2017 Feb; 26(2):204-207. PubMed ID: 27365372
[TBL] [Abstract][Full Text] [Related]
35. [Monoclonal B-lymphocytosis complicated with chronic myelomonocytic leukemia and immune thrombocytopenia: a case report].
Qiu JY; Sha YQ; Shen H; Li JY; Zhu HY
Zhonghua Xue Ye Xue Za Zhi; 2021 Dec; 42(12):1051. PubMed ID: 35045683
[No Abstract] [Full Text] [Related]
36. The clinical management of chronic myelomonocytic leukemia.
Padron E; Komrokji R; List AF
Clin Adv Hematol Oncol; 2014 Mar; 12(3):172-8. PubMed ID: 24927265
[TBL] [Abstract][Full Text] [Related]
37. Outcome of patients with high risk Myelodysplastic Syndrome (MDS) and advanced Chronic Myelomonocytic Leukemia (CMML) treated with decitabine after azacitidine failure.
Harel S; Cherait A; Berthon C; Willekens C; Park S; Rigal M; Brechignac S; Thépot S; Quesnel B; Gardin C; Adès L; Fenaux P; Braun T
Leuk Res; 2015 May; 39(5):501-4. PubMed ID: 25735917
[TBL] [Abstract][Full Text] [Related]
38. Smoking and philadelphia-negative chronic myeloproliferative neoplasms.
Lindholm Sørensen A; Hasselbalch HC
Eur J Haematol; 2016 Jul; 97(1):63-9. PubMed ID: 26384085
[TBL] [Abstract][Full Text] [Related]
39. Eltrombopag Use in Patients With Chronic Myelomonocytic Leukemia (CMML): A Cautionary Tale.
Ramadan H; Duong VH; Al Ali N; Padron E; Zhang L; Lancet JE; List AF; Komrokji RS
Clin Lymphoma Myeloma Leuk; 2016 Aug; 16 Suppl():S64-6. PubMed ID: 27521328
[TBL] [Abstract][Full Text] [Related]
40. A phase I study of lenalidomide in patients with chronic myelomonocytic leukemia (CMML) - AGMT_CMML-1.
Burgstaller S; Stauder R; Kuehr T; Lang A; Machherndl-Spandl S; Mayrbaeurl B; Noesslinger T; Petzer A; Valent P; Greil R; Thaler J
Leuk Lymphoma; 2018 May; 59(5):1121-1126. PubMed ID: 28853315
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
